FDA DrugsClass II
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL via...
Published: April 22, 2026Recall ID: D-0471-2026Category: drugsCountry: US
Reason for Recall / Hazard
Lack of Assurance of Sterility
Product Description & Identification
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Additional Source Details
| Field | Value |
|---|---|
| City | Beaverton |
| State | OR |
| Event id | 98646 |
| Address 1 | 8505 Sw Creekside Pl Ste 110 |
| Address 2 | N/A |
| Code info | Lot Number 01-27-2026@14S.5 |
| Postal code | 97008-7128 |
| Report date | 20260422 |
| Product type | Drugs |
| Product quantity | 91 vials |
| Reason for recall | Lack of Assurance of Sterility |
| Voluntary mandated | Voluntary: Firm initiated |
| Recall initiation date | 20260306 |
| Initial firm notification | Letter |
| Center classification date | 20260413 |
Overview
- Recalling FirmPAYLESS COMPOUNDERS, LLC
- StatusOngoing
- Risk LevelClass II
- DistributionOR